BackAddus HomeCare Overview
Addus HomeCare Corporation

Addus HomeCare Target Price

Analysts' average 12-month price target for Addus HomeCare is $110.

Get informed when a big investor buys or sells

+ Follow

Share Price

$118.06

Average Target Price

$107.339.1% downside

3 analysts in the last 4 months

High: $134 | Low: $92

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-05RBC Capital$13413.5% upsideOpen
2026-07-08BarclaysAndrew Mok$9618.7% downsideOpen
2026-05-15Barclays$9222.1% downsideOpen
2026-02-25RBC CapitalBen Hendrix$13917.7% upsideOpen
2026-02-24Barclays$1125.1% downsideOpen
2026-01-07Truist FinancialClarke Murphy$13514.3% upsideOpen
2025-11-04BarclaysAndrew Mok$1170.9% downsideOpen
2025-09-02UBS$14522.8% upsideOpen
2024-12-16JMP SecuritiesConstantine Davides$15027.1% upsideOpen
2024-11-06StephensScott Fidel$14522.8% upsideOpen
2024-10-10KeyBancMatthew Gillmor$15027.1% upsideOpen
2024-09-23OppenheimerMichael Wiederhorn$14522.8% upsideOpen
2024-08-08RBC CapitalFrank Morgan$14119.4% upsideOpen
2024-08-07OppenheimerMichael Wiederhorn$14018.6% upsideOpen
2024-06-07OppenheimerMichael Wiederhorn$13010.1% upsideOpen
2024-05-31StephensScott Fidel$1288.4% upsideOpen
2024-05-28RBC CapitalFrank Morgan$1299.3% upsideOpen
2024-04-23BarclaysAndrew Mok$8329.7% downsideOpen
2024-04-01StephensScott Fidel$1152.6% downsideOpen
2022-06-29StephensScott Fidel$10114.5% downsideOpen
2022-05-04RBC Capital$1116% downsideOpen

Addus HomeCare (ADUS) FAQ

Addus HomeCare's target price stands at $110. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $110 for ADUS implies 9.1% downside versus today's price ($118.06). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Addus HomeCare's target price evolved across reporting periods, while the comparison chart places ADUS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Addus HomeCare's reading of $110 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.